Document Detail


The acute respiratory distress syndrome: pathogenesis and treatment.
MedLine Citation:
PMID:  20936936     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The acute respiratory distress syndrome (ARDS) causes 40% mortality in approximately 200,000 critically ill patients annually in the United States. ARDS is caused by protein-rich pulmonary edema that causes severe hypoxemia and impaired carbon dioxide excretion. The clinical disorders associated with the development of ARDS include sepsis, pneumonia, aspiration of gastric contents, and major trauma. The lung injury is caused primarily by neutrophil-dependent and platelet-dependent damage to the endothelial and epithelial barriers of the lung. Resolution is delayed because of injury to the lung epithelial barrier, which prevents removal of alveolar edema fluid and deprives the lung of adequate quantities of surfactant. Lymphocytes may play a role in resolution of lung injury. Mortality has been markedly reduced with a lung-protective ventilatory strategy. However, there is no effective pharmacologic therapy, although cell-based therapy and other therapies currently being tested in clinical trials may provide novel treatments for ARDS.
Authors:
Michael A Matthay; Rachel L Zemans
Related Documents :
8337016 - A common presentation of an uncommon cause of neonatal respiratory distress: pneumonia ...
6384296 - Yellow nail syndrome.
1956726 - Weaver syndrome: a case without early overgrowth and review of the literature.
12717596 - Congenital heart disease with hypereosinophilic syndrome.
19448546 - Neuromodulation 10 years on: how widely should we use this technique in bladder dysfunc...
16801186 - Partial cerebellar hypoplasia in a patient with prader-willi syndrome.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Annual review of pathology     Volume:  6     ISSN:  1553-4014     ISO Abbreviation:  Annu Rev Pathol     Publication Date:  2011  
Date Detail:
Created Date:  2011-01-25     Completed Date:  2011-04-25     Revised Date:  2012-03-14    
Medline Journal Info:
Nlm Unique ID:  101275111     Medline TA:  Annu Rev Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  147-63     Citation Subset:  IM    
Affiliation:
The Cardiovascular Research Institute, Department of Medicine, University of California, San Francisco, 94143, USA. michael.matthay@ucsf.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Pulmonary Alveoli / immunology*,  pathology*
Respiratory Distress Syndrome, Adult* / etiology,  pathology,  therapy
Grant Support
ID/Acronym/Agency:
K08 HL103772-01/HL/NHLBI NIH HHS; P01AI1053194/AI/NIAID NIH HHS; R37HL51854/HL/NHLBI NIH HHS; R37HL51856/HL/NHLBI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Why should a doctor be interested in oral disease?
Next Document:  Disorders of bone remodeling.